AnPac Bio-Medical Science... (ANPC)
NASDAQ: ANPC
· Real-Time Price · USD
4.30
-0.14 (-3.15%)
At close: May 19, 2023, 9:59 PM
AnPac Bio-Medical Science Revenue Breakdown
| Period Ending | Dec 31, 2021 |
|---|---|
| Cancer screening and detection tests Revenue | 14.95M |
| Cancer screening and detection tests Revenue Growth | n/a |
| Physical checkup packages Revenue | 1.65M |
| Physical checkup packages Revenue Growth | n/a |
| Retail revenue Revenue | 101K |
| Retail revenue Revenue Growth | n/a |
| Technology services Revenue | 1.28M |
| Technology services Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 30.32M | 23.46M | 15.93M | 13.22M | 25.84M | 23.88M | 29.29M | 23.09M | 23.21M | 15.86M | 6.99M | 23.19M | 23.5M | 30.73M | 12.7M |
| Selling, General, and Administrative Revenue Growth | +29.23% | +47.26% | +20.54% | -48.83% | +8.19% | -18.48% | +26.87% | -0.51% | +46.35% | +126.85% | -69.85% | -1.35% | -23.53% | +142.03% | n/a |
| Research and Development Revenue | 1.61M | 3.59M | 1.92M | 2.41M | 4.34M | 6.25M | 2.26M | 3.36M | 355K | 3.79M | 1.58M | 2.94M | 2.7M | 2.62M | 2.36M |
| Research and Development Revenue Growth | -55.10% | +86.69% | -20.11% | -44.55% | -30.51% | +176.42% | -32.66% | +845.35% | -90.63% | +139.14% | -46.07% | +8.74% | +3.21% | +10.89% | n/a |
| Sales and Marketing Revenue | 3.29M | 3.51M | 2.42M | 2.93M | 4.08M | 6.52M | 6.95M | 3.86M | 9.26M | 5.74M | 2.55M | 3.6M | 2.9M | 4.58M | 2.63M |
| Sales and Marketing Revenue Growth | -6.46% | +44.82% | -17.29% | -28.23% | -37.38% | -6.13% | +79.89% | -58.27% | +61.20% | +125.30% | -29.12% | +23.87% | -36.68% | +74.67% | n/a |